UA109405C2 - 6-(2-r-methylseleno)-4-(2-metoxyphenyl)-2-oxo-1,2,3,4-tetrahydropyridine-3,5-dicarbonitriles - Google Patents

6-(2-r-methylseleno)-4-(2-metoxyphenyl)-2-oxo-1,2,3,4-tetrahydropyridine-3,5-dicarbonitriles

Info

Publication number
UA109405C2
UA109405C2 UAA201114171A UAA201114171A UA109405C2 UA 109405 C2 UA109405 C2 UA 109405C2 UA A201114171 A UAA201114171 A UA A201114171A UA A201114171 A UAA201114171 A UA A201114171A UA 109405 C2 UA109405 C2 UA 109405C2
Authority
UA
Ukraine
Prior art keywords
dicarbonitriles
metoxyphenyl
methylseleno
tetrahydropyridine
oxo
Prior art date
Application number
UAA201114171A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Сергій Геннадійович Кривоколиско
Костянтин Олександрович Фролов
Original Assignee
Східноукраїнський Національний Університет Імені Володимира Даля
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Східноукраїнський Національний Університет Імені Володимира Даля filed Critical Східноукраїнський Національний Університет Імені Володимира Даля
Priority to UAA201114171A priority Critical patent/UA109405C2/en
Publication of UA109405C2 publication Critical patent/UA109405C2/en

Links

Landscapes

  • Hydrogenated Pyridines (AREA)

Abstract

Subject of invention: 6-(2-R-methylseleno)-4-(2-metoxyphenyl)-2-oxo-1,2,3,4-tetrahydropyridine-3,5-dicarbonitriles. Scope of application: organic synthesis. Summary of invention: 6-(2-R-methylseleno)-4-(2-metoxyphenyl)-2-oxo-1,2,3,4-tetrahydropyridine-3,5-dicarbonitriles characterized by 2-methoxyphenyl fragment in position 4 and various alkylseleno groups in position 6. Technical result: 6-(2-R-methylseleno)-4-(2-metoxyphenyl)-2-oxo-1,2,3,4-tetrahydropyridine-3,5-dicarbonitriles that may be used as the potential biologically active substances possessing the targeted pharmacological activity and the initial substances for synthesis of the novel functionally substituted heterocyclic substances. Their structure has been proven by IR- and NMR 1H-spectroscopy, elemental analysis.
UAA201114171A 2011-11-30 2011-11-30 6-(2-r-methylseleno)-4-(2-metoxyphenyl)-2-oxo-1,2,3,4-tetrahydropyridine-3,5-dicarbonitriles UA109405C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAA201114171A UA109405C2 (en) 2011-11-30 2011-11-30 6-(2-r-methylseleno)-4-(2-metoxyphenyl)-2-oxo-1,2,3,4-tetrahydropyridine-3,5-dicarbonitriles

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAA201114171A UA109405C2 (en) 2011-11-30 2011-11-30 6-(2-r-methylseleno)-4-(2-metoxyphenyl)-2-oxo-1,2,3,4-tetrahydropyridine-3,5-dicarbonitriles

Publications (1)

Publication Number Publication Date
UA109405C2 true UA109405C2 (en) 2015-08-25

Family

ID=54772069

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201114171A UA109405C2 (en) 2011-11-30 2011-11-30 6-(2-r-methylseleno)-4-(2-metoxyphenyl)-2-oxo-1,2,3,4-tetrahydropyridine-3,5-dicarbonitriles

Country Status (1)

Country Link
UA (1) UA109405C2 (en)

Similar Documents

Publication Publication Date Title
CL2012003604A1 (en) Heterocyclic compounds derived from substituted pyridine carboxamide; Preparation process; pharmaceutical composition; pharmaceutical combination; use in the treatment of cell proliferative disorders, parkinson's disease, cancer, among others.
BR112013033182A2 (en) substituted imidazopyridinyl aminopyridine compounds
CL2015001358A1 (en) Enhanced cftr enhancers
CR20140161A (en) BENZILINDAZOLS REPLACED FOR USE AS INHIBITORS OF QUINASA BUB1 IN THE TREATMENT OF HYPERPROLIFERATIVE DISEASES
CL2015001985A1 (en) Thiazolcarboxamides and pyridinecarboxamide compounds, pim kinase inhibitors.
CL2015003444A1 (en) Compounds of 3,4 dihydroisoquinolin-2 (1h) -yl
CL2015002609A1 (en) 2-substituted azabicycles and their use as orexin rector modulators.
ECSP14013148A (en) DERIVATIVES OF AZETIDINIL FENIL, PIRIDIL OR PIRAZINIL CARBOXAMIDA AS JAK INHIBITORS
TR201901886T4 (en) DNA-PK inhibitors.
CR20120510A (en) DERIVATIVES OF PIPERIDIN-4-IL AZETIDINE AS INHIBITORS OF JAK1
MX2019008122A (en) Heterocycle amines and uses thereof.
MY185217A (en) Analogs of glucagon exhibiting gip receptor activity
MX2016006432A (en) Tetrahydro-benzodiazepinones.
CR20110620A (en) DERIVATIVES OF N- (HETERO) ARIL-PIRROLIDINA DE PIRAZO-4-IL-PIRROLO [2,3-D] PIRIMIDINES AND PIRROL-3-IL-PIRROLO [2,3-D] PYRIMIDINES AS IHNIBITORS OF THE JANUS KINASE
MX2016008448A (en) Var2csa-drug conjugates.
MX339899B (en) Triazolopyridine compounds as pim kinase inhibitors.
IN2012DN01983A (en)
ECSP13012824A (en) DERIVATIVES OF (1,2,4) TRIAZOLO [4,3-A) QUINOXALINE AS PHOSPHODESTERASE INHIBITORS
PH12016500092A1 (en) New azabenzimidazole derivatives
CL2011001427A1 (en) Compounds derived from 4-azetidinyl-1-heteroaryl-cyclohexanol; pharmaceutical composition; and use in the treatment of diseases such as epoc, atherosclerosis, rheumatoid arthritis, among others.
MX2015007053A (en) Dimeric compounds.
ECSP11011021A (en) ANTAGONISTS OF THE VIA HEDGEHOG OF FTALAZINA DISUSTITUIDA
CL2014003325A1 (en) Compounds derived from difluoro-hexahydro-cyclopentaoxacinyls and difluoro-hexahydro-benzooxacinyls, bace 1 inhibitors; pharmaceutical composition; and its use in the treatment of diseases with elevated levels of beta-amyloid, such as Alzheimer's disease
BR112015021324A2 (en) 6- [4- (1h-imidazol-2-yl) piperidin-1-yl] pyrimidin-4-amine derivatives as kinase activity modulators
CL2009000949A1 (en) Compounds derived from 1,2,3,5-tetrahydro-indolizine, 6,7,8,9-tetrahydro-4h-quinolizine substituted, inhibitors of mek kinase activity; its pharmaceutical composition; its use for the treatment of hyperproliferative diseases, such as cancer and inflammation.